Motion Perception in Individuals With Type 2 Diabetes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03380832|
Recruitment Status : Unknown
Verified October 2018 by Faisal_Karmali@MEEI.HARVARD.EDU, Massachusetts Eye and Ear Infirmary.
Recruitment status was: Recruiting
First Posted : December 21, 2017
Last Update Posted : October 16, 2018
|Condition or disease|
|Diabetes Mellitus, Type 2|
Previous studies have found that individuals with diabetes fall more frequently, have less stable posture, and have reduced motion and touch sensation in the lower extremities. This study will examine whether vestibular sensation is also affected by diabetes.
This study is observational because measurements will be made without the application of an intervention. The same measurement protocol was applied to a large group of normal subjects, and this published data will serve as normative controls.
|Study Type :||Observational|
|Estimated Enrollment :||16 participants|
|Official Title:||Vestibular Perception and Action|
|Actual Study Start Date :||August 1, 2017|
|Estimated Primary Completion Date :||June 1, 2019|
|Estimated Study Completion Date :||June 1, 2019|
Type 2 diabetes for at least 10 years
This is an observational study in which we will quantify vestibular thresholds in individuals who have had type 2 diabetes for at least 10 years. Normative data has recently been published and subjects with diabetes will be compared to a model that includes age effects.
- Vestibular threshold [ Time Frame: 3 hours ]Vestibular thresholds are measured while subjects sit in a chair that makes small motions in a variety of directions. After each motion, subjects press a button to report their perceived direction (e.g., did I rotate to the left or the right). The size of the motions is adjusted based on subject responses to find the level at which they get approximately 80% of responses correct.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03380832
|Contact: Faisal Karmali, PhDemail@example.com|
|United States, Massachusetts|
|Massachusetts Eye and Ear Infirmary||Recruiting|
|Boston, Massachusetts, United States, 02114|
|Contact: Faisal Karmali 410-218-7614 firstname.lastname@example.org|
|Principal Investigator:||Faisal Karmali, PhD||Massachusetts Eye and Ear Infirmary|